Evogene Ltd. (EVGN)
TASE
172.80
-0.50 (-0.29%)
Real-time Data
06:59 AM
Day's Range
171.50175.70
52 wk Range
116.00478.70
Financial Statements - EVGN - Evogene Ltd.
Revenue
3.85M▼ 54.7%
Net Income
-7.82M▲ 56.6%Net Margin -203.1%
EBITDA
-14.05M▲ 27.1%
Free Cash Flow
-13.63M▲ 32.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 3.85M | 8.51M | 5.64M | 1.67M | 930K | 1.04M |
| Cost of Goods | 4.09M | 2.68M | 1.69M | 909K | 767K | 574K |
| Gross Profit | -241K | 5.82M | 3.94M | 766K | 163K | 466K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -14.03M | -22.21M | -26.50M | -26.94M | -30.95M | -24.81M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 1.82M | 3.75M | -454K | -2.57M | 791K | -967K |
| Pre Tax Income | -13.49M | -18.04M | -25.98M | -29.75M | -30.43M | -26.17M |
| Income Tax | 1K | 9K | -33K | 90K | 13K | 32K |
| Net Income | -7.82M | -18.05M | -25.95M | -29.84M | -30.44M | -26.20M |
| EPS Basic | -1.08 | -2.89 | -5.2 | -6.5 | -6.9 | -8.3 |
| EPS Diluted | -1.08 | -2.89 | -5.2 | -6.5 | -6.9 | -8.3 |
| Basic Shares Outstanding | 7.87M | 5.69M | 1.23M | 1.15M | 1.13M | 787.36K |
| Diluted Shares Outstanding | 7.87M | 5.69M | 1.23M | 1.15M | 1.13M | 787.36K |
| Ebit | -13.34M | -17.98M | -25.87M | -29.58M | -30.11M | -25.93M |
| Ebitda | -14.05M | -19.27M | -22.80M | -24.43M | -28.67M | -22.24M |
| Net Income Continuous Operations | -13.49M | -18.05M | -25.95M | -29.84M | -30.44M | -26.20M |
| Minority Interests | -658K | 1.56M | 2.07M | 3.20M | 2.65M | 2.83M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
